FDA: New Warning for Procrit, Epogen, Aranesp - WebMD PDF Print
WebMD
The advice is different for CKD patients on dialysis and for CKD patients not on dialysis. Begin ESA treatment when the hemoglobin level is less than 10 g/dL. If the hemoglobin level approaches or reaches 11 g/dL, reduce the ESA dose or suspend ...
FDA places dose limits on anemia drugs Cardiovascular Business
New Dosing Guidelines for Erythropoiesis-Stimulating Agents Medscape
Breaking news: FDA calls for changes in ESA dosing for patients with chronic

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.